PRMT5 inhibitors and uses thereof
US9388173B2 · kind B2 · utility
32Cited by
29References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2014 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Oct 15, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.